I won't diluteshareholdersMino-Lokis our leadassetI/ONTAKis our leadassetOur Halo-Lido trial willhave finalpatient byend of 2022We haveenough cashto go wellinto 2023We intendto submita BLA in2H 2022We had aphase 2btrial with100%efficacyAnymentionof Mino-WrapWe expect tofinish theMino-Loktrial this yearI'm ashareholdermyselfNot manycompaniesthis size with2 late stageassetsWe will openupinternationalsites forMino-Lok trialI/ONTAKwas thebest deal Iever madeI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We willhaveexclusivityOnly biotechwith 2 Myron'son theleadershipteamThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"Mino-Lokpotentialmarket>$1BInsidersinvested$26.5mAn actualiMSCupdateThere are noFDAapproveddrugs to treathemorrhoidsMyron Holubiakand I founded aprivatecompany in2013I/ONTAK'spotentialmarket is>$300mHemorrhoidsis a $2BmarketI won't diluteshareholdersMino-Lokis our leadassetI/ONTAKis our leadassetOur Halo-Lido trial willhave finalpatient byend of 2022We haveenough cashto go wellinto 2023We intendto submita BLA in2H 2022We had aphase 2btrial with100%efficacyAnymentionof Mino-WrapWe expect tofinish theMino-Loktrial this yearI'm ashareholdermyselfNot manycompaniesthis size with2 late stageassetsWe will openupinternationalsites forMino-Lok trialI/ONTAKwas thebest deal Iever madeI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We willhaveexclusivityOnly biotechwith 2 Myron'son theleadershipteamThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"Mino-Lokpotentialmarket>$1BInsidersinvested$26.5mAn actualiMSCupdateThere are noFDAapproveddrugs to treathemorrhoidsMyron Holubiakand I founded aprivatecompany in2013I/ONTAK'spotentialmarket is>$300mHemorrhoidsis a $2Bmarket

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. I won't dilute shareholders
  2. Mino-Lok is our lead asset
  3. I/ONTAK is our lead asset
  4. Our Halo-Lido trial will have final patient by end of 2022
  5. We have enough cash to go well into 2023
  6. We intend to submit a BLA in 2H 2022
  7. We had a phase 2b trial with 100% efficacy
  8. Any mention of Mino-Wrap
  9. We expect to finish the Mino-Lok trial this year
  10. I'm a shareholder myself
  11. Not many companies this size with 2 late stage assets
  12. We will open up international sites for Mino-Lok trial
  13. I/ONTAK was the best deal I ever made
  14. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  15. We will have exclusivity
  16. Only biotech with 2 Myron's on the leadership team
  17. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  18. Mino-Lok potential market >$1B
  19. Insiders invested $26.5m
  20. An actual iMSC update
  21. There are no FDA approved drugs to treat hemorrhoids
  22. Myron Holubiak and I founded a private company in 2013
  23. I/ONTAK's potential market is >$300m
  24. Hemorrhoids is a $2B market